stella
beta
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1 — Stella
Home
/
NF1
/
View on ClinicalTrials.gov
Recruiting
Back to NF1 trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Johns Hopkins University, Baltimore, Maryland